Resultados de la búsqueda 801-810 of 8949 for preventionin
https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet. Accessed Feb. 13, 2017. Raby BA, et al. Genetic testing. http ...
The purpose of this study is to find out more about certain markers of immune suppression in people with kidney tumors (whether the tumors are benign or cancer) ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
Centers for Disease Control and Prevention. http://www.cdc.gov/flu/about/disease/symptoms.htm. Accessed March 8, 2016. Cutrer FM, et al. Cough, exercise ...
Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...
Office of Disease Prevention and Health Promotion (Oficina de Prevención de Enfermedades y Promoción de la Salud). https:// odphp.health.gov/healthypeople ...
The Registry participants include new participants and participants from the NHO, Genetic I and Genetics II studies who agree to continue to participate. The ...
Centers for Disease Control and Prevention. https://www.cdc.gov/heartdisease/women.htm. Accessed Aug. 30, 2022. Key statistics for breast cancer. American ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...
Centers for Disease Control and Prevention. https://www.cdc.gov/rabies/exposure/animals/bats.html. Accessed Sept. 29, 2020. Baddour LM, et al. Animal bites ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?